In part 2 of Session 3 #ESHRE2024, Prof. Cesar Diaz-Garcia explained how stem cell and ovarian fragmentation treatments can help to restore female fertility. Briefly: -Trials with stem cells transfer saw low changes -After fragmentation, POI patients saw higher pregnancy rate

Join us for our last session: Beyond the immediate: navigating the risks and challenges of preserving and restoring fertility with talks from Rod Mitchell and anna veiga at15:30-17:00.

In part 1 of Session 4 #ESHRE2024, Rod Mitchell outlined the risks of preservation. Fertility risks should be considered for all patients. Counseling and fully informed consents are important. Risks of harvesting depends on underlying diagnosis. Storage has many risks.

In part 2 of Session 4 at PCC4 #ESHRE2024, anna veiga gave a thorough overview of the road to in vitro gametogenesis (IVG). In summary, there is a successful completion of male and female meiosis in vitro. However, in human, IVG is still in the experimental phase.

We just finished our precongress course at #ESHRE2024!!! We want to thank all speakers, chairs and attendees for the interesting sessions and discussions. We also want to thank ESHRE SIG Fertility Preservation for this joined precongres course

After the precongres courses of yesterday, today starts the main program of the 40th Annual Meeting #ESHRE2024 The coming 3 days will be filled with many talks, discussions and networking events For live updates related to stem cells during #ESHRE2024 follow ESHRE SIG Stem Cells

Join us for Session 14 for the Poster discussion Session- Stem cells moderated by Bieke Bekaert at 11:45-12:45 in Elicium 1, floor 1 #ESHRE2024

Join us for the selected oral communications in Session 26: advances and challenges in modelling human reproduction at 15:15-16:30 at Forum, ground floor

In session 26 part 1 #ESHRE2024, Erik Vrij talked about their novel stem cell-based twin embryo model which reveals inner cell mass division and enhanced endometrial adhesion during in vitro monochronioc twin development.

In session 26 part 2 #ESHRE2024, Dr. Nadia Kubikova assessed the genome editing outcomes in human preimplantation embryos subjected to CRISPR-Cas9 and postulated that most loss of heterozygosity events were caused by DNA repair deficiency

In session 26 part 3 #ESHRE2024, Dr. Nicolas Gatimel showed that their human fallopian tube (HFT) organoids can provide a favorable environment for progressive sperm motility. Furthermore, this model can be helpful for understanding HFT.

In session 26 part 4 #ESHRE2024, Aslı Ak described their implantation-on-chip model which is a microfluidics chip consisting of an endometrial monolayer and blastoids. This chip can be used to investigate implantation receptivity and failure.

In session 26 part 5 #ESHRE2024, Dr. Gabby Steba compared the transcriptome of endometrial organoids of fertile and subfertile women exposed to seminal plasma (SP) of fertile men. Based on this data, she concluded that SP might impact the endometrium during implantation.

Join us for the invited Session 49: Stem cells in reproductive medicine: from basic science to clinical applications at 11:45-12:45 at Elicium 2, 1st floor

Please visit the poster area during your breaks and watch many interesting posters. #ESHRE2024

In Session 49 part 1 #ESHRE2024, Prof. Thomas Freour summarized the modelling of early human development and implantation using stem cell models. Embryoids should not be considered as embryos but as a research tool. We should reflect on the many ethical questions.

In Session 49 part 2 #ESHRE2024, Prof. Emre Seli talked about the importance of stem cells in the oocyte research field, their therapeutics potential for ovarian activation and the in vitro generation of gametes.

Join us for session 53; MHR symposium: Basic principles of human development revealed by natural embryos and stem cell-generated embryo models at 14-15 at Hall 8B, 1st floor

In session 53 part 2 #ESHRE2024, Alfonso Martinez Arias explained what gastruloids are and how they can model gastrulation and body plan engineering in development and disease.

Unfortunately the 40th Annual Meeting #ESHRE2024 has finished. We cannot wait to meet everyone again in Paris next year #ESHRE2025 #Paris